Envestnet Portfolio Solutions, Inc. Catalyst Pharmaceuticals, Inc. Transaction History
Envestnet Portfolio Solutions, Inc.
- $23.7 Billion
- Q1 2025
A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 8,690 shares of CPRX stock, worth $211,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,690Holding current value
$211,080% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
363Shares Held
97.4MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$454 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$205 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$141 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$76.1 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$73.2 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.5B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...